Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Luo, Long Chen, P. He, Q. Hu, X. Zhong, Y. Sun, Yuan-Fu Yang, Tinglun Tian, Hong Zheng (2013)Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in a Chinese population.
Asian Pacific journal of cancer prevention : APJCP, 14 4
W. Renner, S. Kotschan, C. Hoffmann, B. Obermayer‐Pietsch, E. Pilger (2000)A Common 936 C/T Mutation in the Gene for Vascular Endothelial Growth Factor Is Associated with Vascular Endothelial Growth Factor Plasma Levels
Journal of Vascular Research, 37
M. Hashemi, E. Eskandari‐Nasab, A. Fazaeli, H. Rezaei, M. Mashhadi, F. Arbabi, M. Taheri (2012)Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
Gene, 505 1
Patrícia Rodrigues, J. Furriol, E. Tormo, S. Ballester, A. Lluch, P. Eroles (2012)The single-nucleotide polymorphisms +936 C/T VEGF and −710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population
Breast Cancer Research and Treatment, 133
Masato Nakamura, Y. Abe, T. Tokunaga (2002)Pathological significance of vascular endothelial growth factor A isoform expression in human cancer
Pathology International, 52
(2006)SNPStats: a web tool for the analysis of association studies
Bioinformatics, 22 15
D. Sa-nguanraksa, Suwattanee Kooptiwut, T. Chuangsuwanich, T. Pongpruttipan, P. Malasit, P. O-Charoenrat (2014)Vascular endothelial growth factor polymorphisms affect gene expression and tumor aggressiveness in patients with breast cancer.
Molecular medicine reports, 9 3
C. Watson, Nicholas Webb, M. Bottomley, P. Brenchley (2000)Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production.
Cytokine, 12 8
Y. Zhang, Yu Yf, Wang Jz, H. Jia (2015)Vascular endothelial growth factor +405G/C and -2578C/A polymorphisms and breast cancer risk: a meta-analysis.
Genetics and molecular research : GMR, 14 3
H. Nasr, K. Chahed, N. Bouaouina, L. Chouchane (2008)Functional vascular endothelial growth factor -2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression.
Clinica chimica acta; international journal of clinical chemistry, 395 1-2
M. Shahbazi, A. Fryer, V. Pravica, I. Brogan, H. Ramsay, I. Hutchinson, P. Harden (2002)Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection.
Journal of the American Society of Nephrology : JASN, 13 1
Quanchi Chen, Zifei Zhou, Liangcheng Shan, Y. Hua, Hui Zeng, Peng-cheng Liu, Z. Cai (2014)Association of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis update.
Biomedical reports, 2 6
N. Ferrara (2002)Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
Seminars in oncology, 29 6 Suppl 16
E. Eskandari‐Nasab, M. Hashemi, H. Rezaei, A. Fazaeli, M. Mashhadi, Simin Moghaddam, F. Arbabi, M. Jahantigh, M. Taheri (2012)Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer
Molecular Biology Reports, 39
A. Act (2014)Breast Cancer: Basic and Clinical Research
M. Hashemi, G. Shahkar, N. Simforoosh, A. Basiri, S. Ziaee, B. Narouie, M. Taheri (2015)Association of polymorphisms in PRKCI gene and risk of prostate cancer in a sample of Iranian Population.
Cellular and molecular biology, 61 5
S. Ajaz, S. Khaliq, A. Abid, A. Hassan, A. Hashmi, G. Sultan, R. Mohsin, Mohammad Mubarrak, S. Naqvi, S. Rizvi, S. Mehdi (2011)Association of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinoma.
Genetic testing and molecular biomarkers, 15 9
T. Nakasaki, H. Wada, Chika Shigemori, C. Miki, E. Gabazza, T. Nobori, Shin Nakamura, H. Shiku (2002)Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer
American Journal of Hematology, 69
Yulan Yan, Hongjie Liang, Tai-jie Li, Shihui Guo, Meng Li, Shan Li, X. Qin (2014)Vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: a meta-analysis of 13 case–control studies
Tumour Biology, 35
J. Rahoui, Y. Sbitti, N. Touil, A. Laraqui, A. Ibrahimi, B. Rhrab, A. bouzidi, Driss Rahali, M. Dehayni, M. Ichou, F. Zaoui, S. Mrani (2014)The single nucleotide polymorphism +936 C/T VEGF is associated with human epidermal growth factor receptor 2 expression in Moroccan breast cancer women
Medical Oncology, 31
Qing Liu, Yan Li, Jian Zhao, Dong-lan Sun, Ya-nan Duan, Na Wang, R. Zhou, Shan Kang (2009)Association of polymorphisms -1154G/A and -2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women.
Human reproduction, 24 10
G. Babu, G. Samari, S. Cohen, T. Mahapatra, R. Wahbe, S. Mermash, O. Galal (2011)Breast cancer screening among females in Iran and recommendations for improved practice: a review.
Asian Pacific journal of cancer prevention : APJCP, 12 7
Kai Wang, Liu Liu, Zheng-ming Zhu, J. Shao, Lin Xin (2011)Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals.
Cytokine, 56 2
Juan Li, Yongjian Ju (2015)Association between the Functional Polymorphism of Vascular Endothelial Growth Factor Gene and Breast Cancer: A Meta-Analysis
Iranian Journal of Medical Sciences, 40
F. Bray, Jiansong Ren, E. Masuyer, J. Ferlay (2013)Global estimates of cancer prevalence for 27 sites in the adult population in 2008
International Journal of Cancer, 132
R. Kapahi, K. Guleria, V. Sambyal, M. Manjari, M. Sudan, M. Uppal, N. Singh (2015)Association of VEGF and VEGFR1 polymorphisms with breast cancer risk in North Indians
Tumor Biology, 36
Meng Zhang, Xun Wu, X. Wang, Duo Zhang, Yongqiang Wang, W. Lu, Z. Cai, Song Wu (2015)Lack of association between +405 G/C polymorphism in VEGF and breast cancer risk: A meta-analysis.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 20 4
N. Ferrara, H. Gerber, J. Lecouter (2003)The biology of VEGF and its receptors
Nature Medicine, 9
S. Schoppmann, R. Horvat, P. Birner (2002)Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review).
Oncology reports, 9 3
M. Hashemi, E. Eskandari‐Nasab, A. Fazaeli, M. Taheri, H. Rezaei, M. Mashhadi, F. Arbabi, M. Kaykhaei, M. Jahantigh, G. Bahari (2012)Association between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian population.
Biomarkers in medicine, 6 6
Jianguo Ma, Weiguo Hu, Ping Zhang, Yujing Sun, Na Wang, Xiaoyan Teng, Q. Qiao (2015)The Association Between VEGF +936C/T and −634G/C Polymorphisms and Breast Cancer Susceptibility, Tumor Growth, and Metastases: Evidence From 20,728 Subjects
Cancer Investigation, 33
Rani James, G. Ramesh, L. Krishnamoorthy, Rahul Bhagat, Shilpa Chadaga, V. Deshmane, G. Ramaswamy (2013)Prevalence of +405G>C,−1154G>A Vascular Endothelial Growth Factor Polymorphism in Breast Cancer
Indian Journal of Clinical Biochemistry, 29
V. Vincenti, Caterina Cassano, M. Rocchi, M. Persico (1996)Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3.
Circulation, 93 8
N. Ferrara (2002)VEGF and the quest for tumour angiogenesis factors
Nature Reviews Cancer, 2
I. Brogan, Naeem Khan, Kevin Isaac, James Hutchinson, V. Pravica, I. Hutchinson (1999)Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene.
Human immunology, 60 12
M. Hashemi, A. Fazaeli, S. Ghavami, E. Eskandari‐Nasab, F. Arbabi, M. Mashhadi, M. Taheri, Wiem Chaabane, Mayur Jain, Marek Łos (2013)Functional Polymorphisms of FAS and FASL Gene and Risk of Breast Cancer – Pilot Study of 134 Cases
PLoS ONE, 8
J. Nagata, H. Kijima, H. Hatanaka, T. Tokunaga, J. Kamochi, Y. Abe, A. Takagi, T. Mine, H. Yamazaki, Masato Nakamura, Y. Ueyama (2002)Angiopoietin-1 and vascular endothelial growth factor expression in human esophageal cancer.
International journal of molecular medicine, 10 4
Lokesh Jain, C. Vargo, R. Danesi, T. Sissung, D. Price, D. Venzon, J. Venitz, W. Figg (2009)The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors
Molecular Cancer Therapeutics, 8
Breast cancer (BC) is one of the most causes of death in women worldwide. It affects Iranian female population approximately a decade earlier than those in other parts of the world. Previous studies have shown that vascular endothelial growth factor (VEGF) gene variants were associated with BC risk. The current study aimed to evaluate the impact of VEGF rs3025039 (+936C>T), rs2010963 (+405C>G), rs833061 (–460T>C), rs699947 (–2578C>A), and rs35569394 (18-bp I/D) polymorphisms on BC risk in an Iranian population in southeast of Iran. This case-control study was done on 250 BC patients and 215 healthy women. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) or PCR was used to genotype the polymorphisms. Our findings showed that VEGF rs699947 variant increased the risk of BC (OR = 1.71, 95% CI = 1.15–2.54, P = 0.009, CA vs CC; OR = 2.12, 95% CI = 1.14–3.93, P = 0.021, AA vs CC; OR = 1.78, 95% CI = 1.22–2.60, P = 0.004, CA+AA vs CC; OR = 1.47, 95% CI = 1.12–1.92, P = 0.005, A vs C). The VEGF rs3025039, rs2010963, rs833061, and rs35569394 variants were not associated with risk/protection of BC. In conclusion, our results proposed that VEGF rs699947 polymorphism may increase the risk of BC development. Furthers studies with larger sample sizes and different ethnicities are necessary to confirm our findings.
Breast Cancer: Basic and Clinical Research – SAGE
Published: Jul 4, 2016
Keywords: vascular endothelial growth factor; VEGF; breast cancer; polymorphism
Access the full text.
Sign up today, get DeepDyve free for 14 days.